Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
Nicolas Hoertel, David R. Boulware, Marina Sánchez‐Rico, Anita Burgun, Frédéric Limosin
Abstract
This cohort study examines the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19.
Topics & Concepts
MedicineRitonavirCoronavirus disease 2019 (COVID-19)CohortInternal medicineDisease2019-20 coronavirus outbreakRetrospective cohort studyVirologyHuman immunodeficiency virus (HIV)Viral loadInfectious disease (medical specialty)Antiretroviral therapyOutbreakCOVID-19 Clinical Research StudiesInfectious Encephalopathies and EncephalitisLong-Term Effects of COVID-19